One study revealed that in IBD patients treated with anti-TNF agents, depression scores significantly decreased from baseline (50.1) to week 6 (48.1, p = 0.02) and week 14 (49.4, p = 0.058), although changes in anxiety scores did not reach statistical significance during the same periods [ 117 ].
← all excerpts
From gut inflammation to psychiatric comorbidity: mechanisms and therapies for anxiety and depression in inflammatory bowel disease.
1
—
—